Steinberg Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Sell
6,451
-12
-0.2% -$2.58K 1.01% 21
2026
Q1
$1.41M Hold
6,463
0.91% 21
2025
Q4
$1.48M Sell
6,463
-112
-2% -$25.5K 1.1% 20
2025
Q3
$1.52M Sell
6,575
-1
-0% -$204 1.09% 21
2025
Q2
$1.22M Sell
6,576
-398
-6% -$74K 0.91% 23
2025
Q1
$1.46M Sell
6,974
-34
-0.5% -$6.61K 1.19% 18
2024
Q4
$1.25M Sell
7,008
-199
-3% -$36.6K 0.92% 19
2024
Q3
$1.42M Sell
7,207
-6
-0.1% -$1.12K 1.09% 20
2024
Q2
$1.24M Hold
7,213
0.97% 22
2024
Q1
$1.31M Hold
7,213
1.11% 21
2023
Q4
$1.12M Hold
7,213
0.99% 25
2023
Q3
$1.08M Sell
7,213
-368
-5% -$54K 0.96% 24
2023
Q2
$1.02M Hold
7,581
0.98% 26
2023
Q1
$1.21M Hold
7,581
1.22% 20
2022
Q4
$1.23M Sell
7,581
-1,581
-17% -$242K 1.33% 17
2022
Q3
$1.23M Hold
9,162
1.31% 18
2022
Q2
$1.4M Sell
9,162
-37
-0.4% -$5.65K 1.48% 15
2022
Q1
$1.49M Hold
9,199
1.37% 17
2021
Q4
$1.25M Sell
9,199
-895
-9% -$106K 1.52% 16
2021
Q3
$1.09M Sell
10,094
-26
-0.3% -$2.97K 1.23% 20
2021
Q2
$1.14M Hold
10,120
1.18% 21
2021
Q1
$1.09M Sell
10,120
-385
-4% -$41.2K 1.28% 21
2020
Q4
$1.13M Sell
10,505
-621
-6% -$59.7K 1.38% 21
2020
Q3
$975K Hold
11,126
1.52% 20
2020
Q2
$1.09M Buy
+11,126
New +$980K 1.93% 20

Other funds holding ABBV

Steinberg Asset Management's ABBV Position: Q2 2026 in Review

Steinberg Asset Management reduced its AbbVie (ABBV) stake by 0.19% in Q2 2026, selling an estimated $2.58K and leaving 6,451 shares worth $1.62M. The position accounts for 1.01% of the portfolio, ranked #21.

Steinberg Asset Management first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Steinberg Asset Management held 6,451 shares of AbbVie worth $1.62M as of Q2 2026.
  • Steinberg Asset Management sold 12 AbbVie shares in Q2 2026, an estimated $2.58K.
  • AbbVie made up 1.01% of Steinberg Asset Management's portfolio in Q2 2026, its #21 holding.
  • Steinberg Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Steinberg Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.